<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 22 Jul 2026 09:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges</title>
   <link>http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;b&gt;Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Showcasing &lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;'s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.in.indpol&quot; idsrc=&quot;xmltag.org&quot; &gt;INDIANAPOLIS&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 22, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4736178-1&amp;amp;h=2321460515&amp;amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fintelligent-lab-solutions-high-precision-instruments-adlm-2026.html&amp;amp;a=Roche&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Swiss:RO&quot; idsrc=&quot;xmltag.org&quot;&gt;Roche&lt;/span&gt;&lt;/a&gt; will showcase integrated diagnostic solutions designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency at the Association for Diagnostics &amp;amp;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Roche+showcases+intelligent+lab+solutions+and+high-precision+instruments+at+ADLM+2026+to+help+laboratories+address+workforce+and+workflow+challenges/26799120.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Raymond James Downgrades Roper Industries (ROP) to Market Perform</title>
   <link>http://www.streetinsider.com/Downgrades/Raymond+James+Downgrades+Roper+Industries+%28ROP%29+to+Market+Perform/26797358.html</link>
   <description>&lt;p&gt;Raymond James analyst Brian Peterson downgraded Roper Industries (NASDAQ: ROP) from Strong Buy to Market Perform with a price target of $500.00.&lt;/p&gt;
&lt;p&gt;For an analyst ratings summary and ratings history on Roper Industries &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=ROP&quot;&gt;click here&lt;/a&gt;. For more ratings news on Roper Industries &lt;a href=&quot;http://www.streetinsider.com/stock_lookup_news.php?q=ROP&amp;amp;type=analyst&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Shares of Roper Industries closed at $350.69 yesterday.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Downgrades/Raymond+James+Downgrades+Roper+Industries+%28ROP%29+to+Market+Perform/26797358.html</guid>
   <pubDate>Wed, 22 Jul 2026 05:55:07 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roper Industries (ROP) PT Lowered to $335 at Mizuho</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Roper+Industries+%28ROP%29+PT+Lowered+to+%24335+at+Mizuho/26791881.html</link>
   <description>Mizuho analyst Brett Linzey lowered the price target on Roper Industries (NASDAQ: ROP) to $335.00  (from $365.00) while maintaining a Underperform rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Roper+Industries+%28ROP%29+PT+Lowered+to+%24335+at+Mizuho/26791881.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:51:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
  <item>
   <title>Roche names new diagnostics North America chief, effective Aug. 1</title>
   <link>http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</link>
   <description>

&lt;p&gt;Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.&lt;/p&gt;

&lt;p&gt;Malarek will succeed Brad Moore, who is retiring at the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:20:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08801724</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39236181</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222322</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00268852</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08637363</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RHHBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
   	  </item>
 </channel>
</rss>
